Skip to main content
. 2020 May 25;29(6):565–571. doi: 10.1159/000508876

Table 4.

Comparison of risk factors between subjects without and with coronary artery stenosis (CAS)

Parameters Subjects without CAS Subjects with CAS p value
Subjects 74 (68.5) 34 (31.5)
Age 0.000
 Q1 ≤ 47 years 21 (91.3) 2 (8.7)
 48 ≤ Q2 ≤ 53 years 27 (79.4) 7 (20.6)
 54 ≤ Q3 ≤ 57 years 10 (47.6) 11 (52.4)
 58 ≤ Q4 years 16 (53.3) 14 (46.7)
Smoking 0.917
 Never 11 (14.9) 5 (14.7)
 Smoker 35 (47.3) 13 (38.2)
 Ex-smoker 28 (37.8) 16 (47.1)
Erectile dysfunction 0.022
 No 37 (50.0) 9 (26.5)
 Yes 37 (50.0) 25 (73.5)
Metabolic factors
 BP ≥130/85 mm Hg or drug 44 (59.5) 23 (67.6) 0.415
 WC ≥90 cm 35 (47.3) 22 (64.7) 0.092
 FBG ≥100 mg/dL or drug 24 (32.4) 19 (55.9) 0.021
 TG ≥150 mg/dL or drug 34 (45.9) 11 (32.4) 0.183
 HDL-C <40 mg/dL or drug 21 (28.4) 10 (29.4) 0.912
Metabolic syndrome 32 (43.2) 17 (50.5) 0.521
TC/HDL-C >3.5 65 (87.8) 24 (70.6) 0.029
HOMA-IR ≥2.34 9 (12.2) 6 (17.6) 0.444

Data are presented as n (%). BP, blood pressure; WC, waist circumference; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment index-insulin resistance. * By χ2 test or linear by linear association.